{"name":"Alzamend Neuro, Inc.","slug":"alzamend-neuro-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPSW9Ba3FWM2xMMnVKMzVoV1pla2ZGX01obkd3Tmc2eFhKTHNLVmR1VkRrcnFnOEpRSnJwdW1DVmxfV0w2N0E2c2xxTV9uTWdTa0N6YzNhTlN4dEFVQ2ZBRWJ4ejhGMDExcmdyWkxRWUNsQXM3T1NDellYN0Z3endxUnh3NkVaNExaRUpPLVdTOUNBMVoxbUI1YkQ5d3o4SmpRVkZ1RUdWVTBNVVg2YVl5TnRDN296T3BxcFU4cHdMa2FBUEdja24ySGJfSW5mVzl6S3JNWnJDZDlfYzA2RV90RnZYVGtVcUlnbjFNd2pmdjlFV1JaTUlJS1dneXd5dkR1VU5VWGlpdVJ2RHpEVlZ0d1FTaWhQQ21qbWVkOTNR?oc=5","date":"2026-04-08","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQenh6RGtIeXZINXo2alNsUVN0RjVxMEhwcjlCRzJ3SHQ1dnE3RVVMUlZLLUg2V3N3TC1Zd1pjNGpHRDc1Q01yVlNMallRRkdPSFBlQlFNQ0Z5MFpGUzdobG1WVDJ5dmRTS2k0bVowal9nTmpJZ3VUUHh5U3NkT2tma25GWGhiZWN2U2RxNHYxR0RlTzlSeFE3V1FoTXVvWUtXREVGUHo4RGh4UkpzanVGTHBR?oc=5","date":"2026-03-27","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's Intraday Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNanlnRUJ4OTVpSFA0d0VQazRTR3ppUHJ4SHBBdnI1TGdSRDFMYW9tSXlMazhEbmdYZEVqRGlERGFKUDlJaThtMjRQUzZXVWlNOFVFLWZ6SHF3Vm8xU2VHbk5DSGFVVTVKd2xEWjZ0aXRLZjRjaEhYenJHVTR4N2F1eG1TZmFGYVlzRFhiR191YlNwYXdaZHhyMldobzk2Z3RvY0ZVTUpKeUw3Q2c?oc=5","date":"2026-03-20","type":"pipeline","source":"Stock Titan","summary":"[8-K] Alzamend Neuro, Inc. Reports Material Event - Stock Titan","headline":"[8-K] Alzamend Neuro, Inc. Reports Material Event","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOTXRXeVVwbWJrVTRRNEx6WDZwYkFOMDNzYzMxR2xvRkJwempudWZDaFRndTF3cDNOeF83OVE4dEZ6ZFBwZ3dzMmhsd1I3NkVwOTJFVE1zVjhVOVRvNWZOTUlXQ1JYY1A3YkxzT20tTWlkNlhDTDgxcDRXNlVwbnhQSE5xXzB1OVBCX0dmcld1NTlod2x4aTM3bUVVYk5SSGdmSU9tWUJtM2ViVW5lMmEwLVVueE5veUVrQi1XcjI0eUY?oc=5","date":"2026-03-16","type":"trial","source":"Stock Titan","summary":"New bipolar trial scans how lithium reaches the brain at Mass General - Stock Titan","headline":"New bipolar trial scans how lithium reaches the brain at Mass General","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxObmF0Vml0cFA1aFlGVExqMm5UWF9GbmFUNjJuNHNsTWVlOVZwN2s4UnJ6RmFHOU81ckxtRHRNelJ1OUVFZHFfb2VoanFVVDNUZGUtWFdlME5WQWdXbmo1V1hOWjNhZGF6VnFBWFNlV2VKYThHNmo4QzBKeUYtM1Rac2NuYm94TDM1SUFUTkhGM3Jsb05Hc3NBaVo3d3k3bUotSmpVYXNLVTBLR0RpcFdET2ZLNEd1Q0ZMcEs4LTZBYXY0ZXJQZ0Z6Ull3SlNOTXRON041Qm8wcTE3eHQycktIRGIxVEtjS1NVQldPTjRNYzl1ZWhrRTQwV2ZSbUNyUktqZVcxUkJ4TmxoV20xaHkwTzZpdUtRdHpRRXZqNGlvLVd6LTA1emZJRElTZVlvbUVWbUNJaUZCdjJxdw?oc=5","date":"2025-11-19","type":"trial","source":"PR Newswire","summary":"Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 \"Lithium in Brain\" Study Conducted at Massachusetts General Hospital - PR Newswire","headline":"Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 \"Lithium in Brain\" Study Con","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNem1kc1ljRWx4bzVDNFVpd2pGckptU1Y3bERiMzRjQUdWODJLTm5WbVVVMS1uUWx2WkxsUUp2YnA0dFlsWFpwWkQzRlJna1AzWlp1N0o3TkJfcHVNMjBlZmFkWnFyejY3Y24yUElYS3ZwblBNQkltQXRLd3BCNmFySXlVY05PZDZFR0ZaaFoxd1k4bnE2Q1lEeVZwQW0yRGYtYlotUjB4amdoQVNWdE9YWGZnNXNvN0lx?oc=5","date":"2025-11-18","type":"pipeline","source":"Investing.com","summary":"Alzamend Neuro announces passing of board member Andrew H. Woo - Investing.com","headline":"Alzamend Neuro announces passing of board member Andrew H. Woo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPR2JfMlo2LUthMFFESW0zOE5LWERZUTZqNmpJd2prcm9rV0FYVEliWjVXY1ZLUXhZTTg5RmF0SmxWbXVhSTgtbTRFY2VQLThsS3ltZ3pyenl0T3pJaGhma1ZoWGRFaUVYZDRnYjNqTzhyWnlKWDExY0puM2JMemdOdmUzdDBaVzlzQ1B0ZDhVNTVBcEJsM2JEYktSR2EwbVZVSVdTMExIdFF2QzlkSlRVX0gtRE9MNFdBT1diNWhKd3A3blpUOHpISnFWYldjckE5T2NQcXlDSkNIc2NjNlhnWm9Kd0ZVck4tanZQZVNPRXFJZDU0a3VHN1gzVlVnLVc4Q1YzRzVNb3g?oc=5","date":"2025-09-11","type":"pipeline","source":"GlobeNewswire","summary":"Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight - GlobeNewswire","headline":"Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFBuelJsUjcyNjJQUkQyLWtKdlRnUHE3ZExwWHBPYjU5TTlnVlR1akdVWFpLUnhobmR4OTlsRjZJTUFQMGhzSEhhbGJQdEhHTU1pWlZ2ZW1ZXzR6ZHJXcHRmWGZ3?oc=5","date":"2025-07-26","type":"pipeline","source":"Quiver Quantitative","summary":"ALZN | Alzamend Neuro, Inc. Common Institutional Ownership - Quiver Quantitative","headline":"ALZN | Alzamend Neuro, Inc. Common Institutional Ownership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRWdNNENHRGc5dVkwWUNOWW9Ka19hWVExYzVhZFJrd2xHMlVxT3RPUzdDMUlRYVNIY2xtWU9CcWZwMkhXbDJReTdRNUJreVBIMlNKTUVjZlpoVGpPQThhMW1hR1ZKR1VvS1NmYlk2eDhuSG1oLVhZeDRMT3kyZWNqWFZxcHp4bHVIOXpQMGJDS3plMXJBbUtOdGRn?oc=5","date":"2025-06-20","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media","headline":"Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AJBVV95cUxQZ0tmWGF3eWZwYmZJQVRmNzNENmZsaWhnSmhZS3dEblRFbTM5QlM2TE1jbGE5QlBySzI1SGtMeXlIWDRFVk8wV25yVlo2TkVGeWs3MXBmMzFZN2I3UUlFb2RkT21vYU1vT2FWTHNDbGFJS1AzQmNESDF0MVdza2o4Y3hXNVVrQUZKMElDUGpWZ3AxLXdJM2syeHI5MDhrWHI2cFFjUE9TOVBPWkxNZlVCeGx3Zlk3aXgxTFEtTjNSTnJTWi1ISWlXQmNUM3hkY1NPMGxrRXZOcHRYaFVRZXBmaEY4SlNnQjBicF9mTWNYNmpIR0RyLWxtS2NsZ1dzeDZueWQ5cjBKcThVTUdjSkhkU1htLVZ0NmlKNEpRdUdSNnJQVHVSa0pxajBqU3ZmbmY4SUlQa09OOEZiTnFCTTRCRUtxY2s1dmlydlNmbmJFMm8zS09FNzFsODEzTmp2NTZ2?oc=5","date":"2025-02-19","type":"trial","source":"Business Wire","summary":"Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital - Business Wi","headline":"Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five U","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE13aElvdXBocWJNYUlXbTRrb2lOT2V2ai1Ob1dSaGJ5QjVEekRUVU5yczlXMVVHSDNVbjktSDBsalp4YVdZRlhQZFlkZW5VVkhN?oc=5","date":"2024-03-03","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBvUEk0YWhPdGFjTWRGSDU5SmtURFNtbFUwNHo5eWpZc2d5bkd3QkVUNkRUZjhwaFo1R3BEMDhXNEpUa1RmUWRiN1hocjdKRFJQMWdJdlJDdklvQ0Ri?oc=5","date":"2021-06-15","type":"pipeline","source":"TradingView","summary":"ALZN Stock Price and Chart — NASDAQ:ALZN - TradingView","headline":"ALZN Stock Price and Chart — NASDAQ:ALZN","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}